Roger C. Lipitz Center News and Updates
Annual Reports
Our annual reports offer an in-depth look at the Center’s work, accomplishments of our students and faculty, and our publications for the year.
Read the Newsletter
The quarterly newsletter is the best way to learn about the Center’s latest research and policy initiatives, collaborations, and publications
Explore the Newsletter Archive
2023 newsletters
2022 newsletters
2021 newsletters
2020 newsletters
2019 newsletters
2018 newsletters
Bloomberg School Stories
Caregivers Need Care, Too
Nearly all older adults with Alzheimer’s disease rely on the help of family and other unpaid help. Experts on aging share essential tips and resources for these caregivers to also care for themselves.
Spending on Consumer Advertising for Top-Selling Prescription Drugs in U.S. Favors Those With Low Added Benefit
Analysis found that more than two-thirds of top-selling prescription drugs in U.S.—one of two countries that allows direct marketing to consumers—were rated as having low added benefit compared to other drugs in 2020.
Why Eli Lilly’s Insulin Price Cap Announcement Matters
Insulin manufacturer Eli Lilly follows the government’s lead with a $35 price cap. Will manufacturers follow suit?